Is the weighted genetic risk score associated with Dupuytren disease recurrence?

Recruiting

• Conditions: Dupuytren disease; palmar fibromatosis; 10010761

• Registration Number: NL-OMON47331
• Lead Sponsor: niversitair Medisch Centrum Groningen

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 28 February 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: Not specified
• Target Recruitment: 677

Inclusion Criteria

- Dupuytren disease patient
- participant in the GODDAF study (METc2007.067)
- genetic data passed the quality control
- surgical treatment of DD
- written informed consent

Exclusion Criteria

- Decisionally incapacitated
- Patients treated for DD with collagenase or radiotherapy

Study & Design

• Study Type: Observational non invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>The presence of recurrent Dupuytren disease.</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>Severity of recurrence. </p><br>